Drug
Angiotensin Conversing Enzyme Inhibitors Enalapril
Angiotensin Conversing Enzyme Inhibitors Enalapril: highest development phase Phase 3, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| - Angiotensin conversing enzyme inhibitors: enalapril, captopril, lisinopril, ramipril, trandolapril. NCT01437371 | Phase 3 | Heart Failure |
Latest
No recent events.
Follow Angiotensin Conversing Enzyme Inhibitors Enalapril on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.